<?xml version="1.0" encoding="UTF-8"?>
<ref id="BST-47-1757C143">
 <label>143</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Hangas</surname>
    <given-names>A.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Aasumets</surname>
    <given-names>K.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kekäläinen</surname>
    <given-names>N.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Paloheinä</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Pohjoismäki</surname>
    <given-names>J.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gerhold</surname>
    <given-names>J.</given-names>
   </name>
   <etal>et al.</etal>
  </person-group> (
  <year>2018</year>) 
  <article-title>Ciprofloxacin impairs mitochondrial DNA replication initiation through inhibition of topoisomerase 2</article-title>. 
  <source>Nucleic Acids Res.</source>
  <volume>46</volume>, 
  <fpage>9625</fpage>–
  <lpage>9636</lpage>
  <pub-id pub-id-type="doi">10.1093/nar/gky793</pub-id>
  <pub-id pub-id-type="pmid">30169847</pub-id>
 </mixed-citation>
</ref>
